Distribute healthcare to all: the lowest-cost path the country has not yet taken

International comparison cuts through the partisan fog. On a per-capita basis the United States spends nearly twice as much on healthcare as Germany and roughly four times as much as South Korea. The headline outcomes do not follow the spending. US life expectancy was 77.0 years in 2020 and 78.4 in 2023 — three to four years below the OECD average and the lowest among high-income countries. Maternal mortality is roughly 24 deaths per 100,000 live births, more than four times the peer-country rate of about 5. Infant mortality is 5.4 per 1,000 live births, against 1.6 in Norway and around 3 in the best-performing peer systems.

The pattern of excess is informative. Roughly 60% of US excess spending versus peer countries is driven by administrative overhead, inflated pharmaceutical prices, and elevated clinician wages — not by a greater volume of clinical care delivered. By volume the US has fewer physicians and beds per capita than its peers (2.8 beds per 1,000 against an OECD average of 4.3), but performs 44% more MRI scans and 62% more CT scans than the average. The system is optimized for high-intensity, high-cost imaging and specialty care rather than primary prevention. Hospitalizations for diabetes and hypertension — conditions highly preventable with timely primary care — are 50% higher than the OECD average. The US rate of hypertension hospitalizations is roughly eightfold higher than the Netherlands, the UK, and Canada. Sixteen percent of US adults use the emergency department for non-urgent care because primary-care access is blocked by financial barriers; the figure is 5% in the Netherlands and 7% in Germany.

Sources: OECD Health Statistics 2024; Commonwealth Fund US-vs-peer comparisons; CDC NCHS; Federal Reserve Financial Accounts.

Employer-sponsored health insurance is a historical accident — a workaround for World War II wage controls preserved in the tax code ever since. The structural consequences for the labor market are well documented and substantial. Job lock deters employees from changing jobs, starting businesses, or returning to school because doing so threatens coverage. Human capital mis-allocates; productivity is suppressed; entrepreneurship is taxed by a risk the rest of the OECD does not have.

When serious illness strikes, the same coupling creates a destructive feedback loop. Research shows illness leads to employment termination for about 38% of patient families.The patient loses income at the exact moment medical liabilities spike — and loses employer-sponsored coverage along with the job. COBRA is mathematically impossible for most displaced workers: the average family COBRA premium exceeds $1,000 per monthagainst an average unemployment benefit of $1,425 per month. The former math does not work even before rent, food, and the patient's own out-of-pocket medical bills.

The downstream effect is documented and large. A landmark Harvard study found that 62% of all US personal bankruptcies were attributable in part to medical expenses. The detail that usually surprises readers: 78% of those medically bankrupted had private health insurance at the onset of illness.Average out-of-pocket medical cost for the insured bankrupts was close to $18,000. Standard private coverage does not insure against financial collapse.

At population scale the lost productivity is measurable. Health-related work losses (absenteeism plus presenteeism) cost US employers more than $260 billion a year. Lost productivity from the uninsured population alone runs an estimated $124–248 billion a year in shortened lifespans and degraded labor-force participation. The uninsurance is structural: it does not exist in any other high-income country.

The single largest line item in US healthcare excess spending is not care. It is the cost of paying for care. Per OECD-comparison studies, about 60% of US excess spending versus peer nations is administrative overhead, drug-price inflation, and clinician-wage premium — not greater volume of clinical service. Single-payer systems operate with substantially lower administrative burden because providers bill one schedule rather than dozens.

The multi-payer structure also produces predictable risk-selection behavior. When different payers reimburse the same clinical service at vastly different rates, providers prioritize the highest-paying patients. Germany's two-tier insurance system is the canonical example: outpatient reimbursement rates for privately insured patients are two to three times those for publicly insured, and a randomized field experiment found publicly insured patients waited thirteen weekdays longer than privately insured patients for identical specialist appointments. The mechanism is not provider malice. It is the predictable response of any market to unequal prices for the same product.

The same dynamic plays out inside the US individual insurance market. Noncompliant plans (short-term, grandfathered) cream-skim healthy enrollees out of the ACA risk pool, leaving sicker, higher- cost lives behind in the compliant marketplaces, which pushes premiums up and accelerates the cycle. For-profit hospitals across the broader US market consistently report lower levels of uncompensated care as a share of net patient revenue than their non-profit counterparts — the shortfall absorbed by public hospitals and non-profit hospitals on uncompensated-care lines.

The waste compounds geographically. About 81% of US counties are healthcare deserts in at least one category — pharmacy, primary care, trauma, or hospital beds — and more than 120 million Americans live in one. The volume-based fee-for-service payment model is structurally hostile to low-density markets: rural hospitals cannot generate enough billable volume to cover fixed overhead, so they close. Between 2010 and 2022, 238 rural hospitals shut their obstetric units; only 41% of rural hospitals still have an active birthing service, and by 2024 roughly one-third of US counties had no obstetric provider or birthing facility at all.

The Accord's COMPASS shortage-indicator suite already names the mechanism: maternity-care deserts, trauma-access deserts, and primary- care HPSAs each trigger automatic Accord program activation when a tract crosses threshold. See /compass for the tract-level measurement and program-trigger architecture.

Defensive medicine — tests, procedures, or referrals ordered primarily to reduce malpractice exposure rather than to benefit the patient — is pervasive in US clinical practice. The Office of Technology Assessment's framing remains the standard: defensive medicine occurs “when doctors order tests, procedures, or visits, or avoid high-risk patients or procedures primarily (but not necessarily solely) to reduce their exposure to malpractice liability.”

The financial drain is large. The US medical liability system costs roughly $55.6 billion a year, of which more than 82% — about $45 billion — is defensive medicine. Broader estimates run $100–180 billion a year, or 5–9% of the national healthcare budget. A hospitalist study found 28% of all medical orders were placed defensively, contributing to roughly 13% of total hospitalization costs. In Pennsylvania, 93% of surveyed physicians reported practicing defensively, with 43% naming advanced imaging as the most overused tool. In Massachusetts the figure was 83%, with 18–28% of all tests, procedures, and referrals ordered solely to manage liability.

The empirical irony is sharp. Higher-spending physicians face significantly fewer malpractice claims, which structurally rewards exhaustive over-testing regardless of clinical utility. High-risk specialties spend roughly 25% of a career defending claims even though about 80% of claims are ultimately resolved without finding of merit. The cost of the resulting clinical overutilization is paid by the patient: unnecessary CT radiation exposure, contrast-dye reactions, procedural complications, and antibiotic resistance from defensive broad-spectrum prescribing.

The same momentum is visible at the end of life, where the system is structurally biased toward intervention over comfort. Roughly 25% of the Medicare budget is spent on patients in their last year of life, a share that has barely moved in two decades. Polypharmacy is heavy: 29–51% of patients with limited life expectancy remain on chronic preventive medications — statins, anticoagulants, antihypertensives — whose time-until-benefit exceeds the patient's remaining survival window. Established deprescribing frameworks (STOPPFrail, Beers Criteria, the Holmes model) exist and are clinically sound, but adoption is limited; structured training is scarce; caregivers often experience discontinuation as abandonment. Hospice care, the right answer for many of these patients, is systematically underutilized: more than 25% of US hospice patients are enrolled for seven days or fewer, a window too short to deliver the therapeutic and holistic benefits of the program.

The Accord's Distributed Healthcare architecture is a payment-side consolidation that preserves clinical plurality on the delivery side. A single federal payer pays all medical claims under the essential floor on a standardized schedule. The clinical care is delivered by three established models, all of which already exist at scale in the US:

Optional private insurance sits outside the single payer for elective, cosmetic, premium, and tail-risk care. The universal floor covers medical, hospital, prescription, dental, vision, hearing, mental health, substance-use treatment, and long-term care.

The cost-discipline mechanism is structural rather than discretionary. The American Healthcare Quality Board (AHQB) — a Senate-confirmed, methodology-audited expert panel — sets reference pricing and holds the 16.8%-of-GDP Healthcare Cost Brake, an automatic stabilizer that triggers fee clawbacks of 0–2% when total system spending crosses the corridor. Target at maturity: roughly 12% of GDP system-wide (federal ~11% + optional private ~1.1% + out-of-pocket ~0.5%), well below the brake.

The rollout is capacity-gated over four to six years with explicit phase-rollback authority. See /healthcare for the full mechanism, phase-by-phase, and /governance/debt-sunset for the macrogovernor that holds the system inside the corridor.

The architecture compounds. Moving from 17.8% to roughly 12% of GDP at maturity recovers an order of $1.5 trillion a year in directly comparable savings. The bigger gains land downstream:

• Job lock dissolves. Coverage is no longer tied to a payroll job. Labor mobility recovers; entrepreneurship is no longer a tax on coverage. The $260 billion in annual employer work-loss cost shrinks; the $124–248 billion in uninsured-population productivity drag closes entirely.
• Medical bankruptcy as a category ends. The feedback loop that converts physical illness into financial ruin is severed at the structural step. The 62% bankruptcy share — and the 78% of medically bankrupted who already had insurance — both go to zero by mechanism, not by sympathy.
• Defensive medicine collapses against the AHQB safe harbor. When reimbursement rides on a Board-set schedule and the schedule itself defines the clinical standard of care, malpractice exposure for following the schedule evaporates. The $45–180 billion annual defensive-medicine drain unwinds. Antibiotic stewardship recovers along with it.
• Pharmacy benefit manager and interchange-style middleman extraction unwinds. One payer cannot be played against thirty. Drug-price inflation, the second- largest line in the 60% peer-comparison excess, comes down through reference pricing.
• The desert-collapse is reversed by the VHA-public lane. Maternal mortality, rural OB closure, and the one-third of counties without an obstetric provider are addressed by mobile-telehealth hybrid units extending VHA capacity into the COMPASS-flagged tracts that need it.
• End-of-life intensity becomes optional, not structural. Capitated payment models give integrated-care providers economic reason to enroll patients in hospice on the clinical timeline rather than the seven-day terminal-week timeline. The 25% Medicare last-year share comes down; the patient's wishes are likelier to be honored.

The architecture is a recombination of three delivery models already operating at scale in the United States(Medicare, Kaiser-Permanente, the VHA). The country already runs each piece. It has never run them under one payer.

• /healthcare — Engine 2 mechanism page. The full Distributed Healthcare architecture: AHQB pricing, the 16.8% Cost Brake, phase-by- phase rollout, and the single-payer / three-delivery-types integration.
• /governance/debt-sunset — the macrogovernor framework. Where the Healthcare Cost Brake sits among the Accord's six automatic stabilizers.
• /compass — the tract-level shortage-indicator suite. Maternity-care desert, primary-care HPSA, mental-health-provider shortage, and trauma-access desert all trigger Accord program activation when a tract crosses threshold.
• /calculator/family — household-level impact. Enter income, household size, and region; the calculator models the move from employer-tied premiums to the universal floor.